Sign In
Buy CCXI
$10.24
+0.0150 (+0.147%)
At Close: Jun 03, 2026
Geode Capital Management LLC Has $22.68 Million Stock Holdings in ChemoCentryx Inc (NASDAQ:CCXI)
11:04am, Wednesday, 15'th Apr 2020
Geode Capital Management LLC raised its holdings in shares of ChemoCentryx Inc (NASDAQ:CCXI) by 11.1% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission.
AQR Capital Management LLC Acquires Shares of 5,612 ChemoCentryx Inc (NASDAQ:CCXI)
09:22am, Monday, 13'th Apr 2020
AQR Capital Management LLC acquired a new stake in ChemoCentryx Inc (NASDAQ:CCXI) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC).
ChemoCentryx (NASDAQ:CCXI) Downgraded by Zacks Investment Research
11:22am, Sunday, 12'th Apr 2020
Zacks Investment Research lowered shares of ChemoCentryx (NASDAQ:CCXI) from a buy rating to a hold rating in a research report released on Wednesday morning, Zacks.com reports. According to Zacks, “
ChemoCentryx Inc (NASDAQ:CCXI) Receives Consensus Rating of "Buy" from Brokerages
10:36am, Sunday, 12'th Apr 2020
ChemoCentryx Inc (NASDAQ:CCXI) has received an average recommendation of “Buy” from the nine analysts that are currently covering the company, Marketbeat Ratings reports. One analyst has rated the
Alliancebernstein L.P. Increases Stock Holdings in ChemoCentryx Inc (NASDAQ:CCXI)
09:53am, Sunday, 12'th Apr 2020
Alliancebernstein L.P. increased its stake in shares of ChemoCentryx Inc (NASDAQ:CCXI) by 48.7% during the 4th quarter, HoldingsChannel.com reports. The firm owned 88,150 shares of the biopharmaceutic
Stock Market's Next Move
07:00pm, Thursday, 09'th Apr 2020
The market remains unsettled but is moving higher as it expects good things to happen after the hot spots peak. The impact of the pandemic will keep expanding d
Cubist Systematic Strategies LLC Sells 8,499 Shares of ChemoCentryx Inc (NASDAQ:CCXI)
09:20am, Wednesday, 08'th Apr 2020
Cubist Systematic Strategies LLC reduced its position in shares of ChemoCentryx Inc (NASDAQ:CCXI) by 31.7% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commis
Hedge Funds Are Betting On Progyny, Inc. (PGNY)
09:16pm, Tuesday, 07'th Apr 2020
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
ChemoCentryx (CCXI) Upgraded to Buy: What Does It Mean for the Stock?
04:00pm, Tuesday, 07'th Apr 2020
ChemoCentryx (CCXI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
ChemoCentryx (CCXI) Upgraded to Buy: What Does It Mean for the Stock?
04:00pm, Tuesday, 07'th Apr 2020
ChemoCentryx (CCXI) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Homology Medicines (FIXX) Gets a Buy Rating from Canaccord Genuity
10:04am, Monday, 06'th Apr 2020
In a report released today, Michelle Gilson from Canaccord Genuity reiterated a Buy rating on Homology Medicines (FIXX), with a price target of $37.00.
Homology Medicines (FIXX) Gets a Buy Rating from Canaccord Genuity
10:04am, Monday, 06'th Apr 2020
In a report released today,
Michelle Gilson
from Canaccord Genuity reiterated a
Buy
rating on Homology Medicines (
FIXX
–
Research Report
), with a price target of
$37.00
. The company’s shares cl
Canaccord Genuity Keeps Their Buy Rating on Homology Medicines (FIXX)
10:04am, Monday, 06'th Apr 2020
Canaccord Genuity analyst Michelle Gilson maintained a Buy rating on Homology Medicines (FIXX) on April 3 and set a price target of $37.00. The company's
Canaccord Genuity Keeps Their Buy Rating on Homology Medicines (FIXX)
10:04am, Monday, 06'th Apr 2020
Canaccord Genuity analyst Michelle Gilson maintained a Buy rating on Homology Medicines (FIXX – Research Report) on April 3 and
Brokers Issue Forecasts for ChemoCentryx Inc's Q1 2020 Earnings (NASDAQ:CCXI)
05:28am, Monday, 06'th Apr 2020
ChemoCentryx Inc (NASDAQ:CCXI) – Stock analysts at SVB Leerink issued their Q1 2020 earnings per share estimates for ChemoCentryx in a research report issued on Wednesday, April 1st. SVB Leerink ana
